Building a Prospective Clinical Database for Diagnosis and Treatment of Liver Cancer

What this Trial Is About

Researchers are conducting a prospective, observational study to build a clinical database for liver cancer diagnosis and treatment. The study focuses on collecting comprehensive diagnostic, treatment, and long-term outcome information from patients treated at the Department of Hepatobiliary and Pancreatic Surgery. This database will help evaluate prognosis and treatment effectiveness in real-world clinical practice, supporting better clinical decisions in the future. Participants are grouped based on their treatment approach, including those undergoing liver resection surgery and those receiving systemic therapy combined with locoregional interventions such as PD-1 inhibitors and targeted drugs. The study observes these treatments without assigning interventions, reflecting real-world patient care. Throughout the study, participants overall survival is tracked from treatment until death from any cause, with assessments up to 100 months. Researchers also monitor adverse events within 30 days after treatments. Data collection includes full diagnostic and therapeutic details alongside long-term follow-up to understand treatment outcomes and safety. The study will run from January 2026 through December 2029.

Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment